FINES AND LAWSUITS
Back in 2004, Johnson & Johnson and its affiliate company were being investigated for their aggressive marketing of Risperdal which was targeting disabled children, as well as for providing kickbacks to pharmacists and doctors.
These legal issues were eventually settled with the U.S. Department of Justice for $2.2 billion. In addition, there was a $181 million settlement with 36 different states.
The manufacturer has promoted Risperdal for uses that have been deemed to be unsafe by the FDA. This is illegal conduct. In addition to marketing Risperdal for unapproved usages, the manufacturer also made numerous misleading statements and false claims about the drug’s safety.
Risperdal lawsuits are only one of the many types of product liability lawsuits that have been filed against Johnson & Johnson. A startlingly large number of their products have been investigated by the government, and the company has also issued a countless number of recalls of their products.
Despite all the Risperdal breast enlargement lawsuit settlements and numerous other product liability lawsuits, Johnson & Johnson’s profits continue to remain on the rise. For the year 2013, the company reported that they had greater than $71 billion in sales. These cases can be discussed in length by a Risperdal lawyer.